The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InWealthfront Advisers LLC significantly increased its stake in Colgate-Palmolive (CL) by 30.9%, acquiring 207,417 shares valued at $16.58 million. This move contributes to a robust total institutional ownership of 80.41% in the consumer goods giant. The increased investment follows Colgate-Palmolive's strong fourth-quarter earnings report, which surpassed consensus estimates. Financial analysts maintain a "Moderate Buy" rating for CL, setting an average target price of $94.47. This confluence of increased institutional confidence, strong financial performance, and positive analyst sentiment underscores a bullish outlook for the stock.